Bühlmann Laboratories AG: Clinical Trials

7 trials sponsored by Bühlmann Laboratories AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 unknown. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Enrolling by invitation 1

Follow Bühlmann Laboratories AG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flow CAST® Peanut Trial
Basophil activation test - Peanut Allergies
Not yet recruitingBühlmann Laboratories AG2452026-10-012026-08-20
BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study)
Allergy Testing, Peanut Allergies
CompletedBühlmann Laboratories AG382026-05-152026-07-17
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
Infliximab, Adalimumab - Inflammatory Bowel Diseases, Crohn Disease
Phase 4Enrolling by invitationUniversity Medical Center Groningen1482021-03-112025-01-06
BÜHLMANN FPELA in the Diagnosis of Exocrine Pancreatic Insufficiency
BÜHLMANN fPELA assay - Exocrine Pancreatic Insufficiency
CompletedBühlmann Laboratories AG2012020-11-012024-12-16
IBDoc® Canadian User Performance Evaluation
IBDoc calprotectin test, questionnaire - Inflammatory Bowel Diseases
Not applicableCompletedBühlmann Laboratories AG612017-05-052018-01-24
Calprotectin for Rapid Diagnostic Infection Spontaneous of Ascites
dosage of calprotectin - Rapid Diagnosis of Spontaneous Infection of Ascitic Fluid
UnknownCentre Hospitalier Universitaire de Besancon2182015-02-012018-07-18
BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS
fecal calprotectin level - Inflammatory Bowel Disease, Irritable Bowel Syndrome
CompletedBühlmann Laboratories AG4782015-01-012019-01-18

Conditions studied

Inflammatory Bowel Diseases (3)  ·  Colitis, Ulcerative (2)  ·  Crohn Disease (2)  ·  Peanut Hypersensitivity (2)  ·  Disease (1)  ·  Dust Mite Allergy (1)  ·  Exocrine Pancreatic Insufficiency (1)  ·  Food Hypersensitivity (1)  ·  Hypersensitivity (1)  ·  Irritable Bowel Syndrome (1)  ·  Venom Hypersensitivity (1)

Interventions

Adalimumab (1)  ·  Basophil Degranulation Test (1)  ·  CT-P13 (1)  ·  Infliximab (1)  ·  Surveys and Questionnaires (1)

Countries

Germany (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Allison Gorman (1)  ·  Greg Rosenfeld, MD (1)  ·  Jonas Rosendahl, MD (1)  ·  Patrick F van Rheenen, MD PhD (1)

Results publications

PMID 30535387, PMID 34732500, PMID 39390697